Free Trial

Vera Therapeutics (VERA) SEC Filings & 10K Form

$37.20
-0.96 (-2.52%)
(As of 09/6/2024 ET)

Recent Vera Therapeutics SEC Filings

DateFilerForm TypeView
08/30/2024
3:04 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:40 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:31 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:24 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
3:36 PM
Vera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:15 PM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:30 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
8:27 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
8:32 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:55 PM
Vera Therapeutics (Filer)
Form ARS
04/03/2024
4:00 PM
Vera Therapeutics (Filer)
Form DEF 14A
04/03/2024
4:02 PM
Vera Therapeutics (Filer)
Form DEFA14A
03/26/2024
7:35 PM
Vera Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:57 PM
Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
03/25/2024
8:46 PM
Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:54 PM
Katabi Maha (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
6:30 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:11 PM
Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
02/14/2024
2:21 PM
Ares Trading S.A. (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
02/14/2024
11:49 AM
Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
02/09/2024
9:05 AM
FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
02/05/2024
3:45 PM
Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
02/01/2024
4:58 PM
Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:52 PM
Vera Therapeutics (Filer)
Form 424B5
01/30/2024
3:54 PM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
8:58 PM
Vera Therapeutics (Filer)
Form S-3MEF
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Vera Therapeutics (Subject)
Form SC 13G
01/29/2024
3:27 PM
Lin Celia (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
7:46 AM
Vera Therapeutics (Filer)
Form 424B5
01/29/2024
5:05 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
5:31 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:54 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
8:55 PM
COMMODORE CAPITAL LP (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:17 AM
Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:03 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:05 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:15 AM
Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
3:15 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
8:02 AM
FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
The death of Nvidia? (Ad)

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.
11/09/2023
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VERA) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners